The final proposal includes $69 billion for the distribution of a coronavirus vaccine and more than $22 billion for states to conduct testing, tracing and coronavirus mitigation programs.
Reprinted for educational purposes and social benefit, not for profit.
RULES COMMITTEE PRINT 116–68 TEXT OF THE HOUSE AMENDMENT TO THE SENATE AMENDMENT TO H.R. 133 [Showing the text of the Consolidated Appropriations Act, 2021]
Page 1598: $4 billion for Gavi. BILATERAL ECONOMIC ASSISTANCE 11 FUNDS APPROPRIATED PRESIDENT TO THE GLOBAL HEALTH PROGRAMS. For an additional amount for ‘‘Global Health Programs’’, $4,000,000,000, to remain available until September 30, 2022, to prevent, prepare for, and respond to coronavirus, including for vaccine procurement and delivery: Provided, That such funds shall be administered by the Administrator of the United States Agency for International Development and shall be made available as a contribution to The GAVI Alliance: Provided further, That such amount is designated by the Congress as being for an emergency requirement pursuant to section 23 251( b)(2)(A)(i) of the Balanced Budget and Emergency 24 Deficit Control Act of 1985.
Page 1827: For an additional amount for ‘‘CDC–Wide Activities Program Support’’, $8,750,000,000, to remain available until September 30, 2024, to prevent, prepare for, and respond to coronavirus, domestically or internationally:
Page 1830. $300,000,000 shall be for high-risk and underserved populations, including racial and ethnic minority populations and rural communities…. show an informational campaign to inform both the public and health care providers will be executed, and how the strategy and plan will focus efforts on high-risk and underserved populations, including racial and ethnic minority populations:
Page 1840. For an additional amount for ‘‘Public Health and Social Services Emergency Fund’’, $22,945,000,000, to remain available until September 30, 2024, to prevent, prepare for, and respond to coronavirus, domestically or internationally, including the development of necessary countermeasures and vaccines, prioritizing platform-based technologies with U.S.-based manufacturing capabilities, the purchase of vaccines, therapeutics, diagnostics, necessary medical supplies, as well as medical surge capacity, and other preparedness and response activities:
Page 1842. That of the amount appropriated under this paragraph in this Act, $19,695,000,000 shall be available to the Biomedical Advanced Research and Development Authority for necessary expenses of manufacturing, production, and purchase, at the discretion of the Secretary, of vaccines, therapeutics, and ancillary supplies necessary for the administration of such vaccines and therapeutics:
Page 1844. For an additional amount for ‘‘Public Health and Social Services Emergency Fund’’, $22,400,000,000, to remain available until September 30, 2022, to prevent, prepare for, and respond to coronavirus, domestically or internationally, which shall be for necessary expenses for testing, contact tracing, surveillance, containment, and 1mitigation to monitor and suppress COVID–19, including tests for both active infection and prior exposure, including molecular, antigen, and serological tests, the manufacturing, procurement and distribution of tests, testing equipment and testing supplies, including personal protective equipment needed for administering tests, the development and validation of rapid, molecular point-of-care tests, and other tests, support for workforce, epidemiology, to scale up academic, commercial, public health, and hospital laboratories, to conduct surveillance and contact tracing, support development of COVID–19 testing plans, and other related activities related to COVID–19 testing and mitigation:
Page 4556. ‘‘SEC. 313. PUBLIC AWARENESS CAMPAIGN ON THE IMPORTANCE OF VACCINATIONS. There 25 are authorized to be appropriated to carry out this section December 21, 2020 (7:54 a.m.) U:\2021OMNI\14OMNI\DivO-FF.xml SEN. APPRO. 2093 1 and subsections (k) and (n) of section 317, $15,000,000 for each of fiscal years 2021 through 2025.’’.
Page 4562. VACCINATION DATA.—The Secretary, acting through the Director of the Centers for Disease Control and Prevention, shall expand and enhance, and, as appropriate, establish and improve, programs and conduct activities to collect, monitor, and analyze vaccination coverage data to assess levels of protection from vaccine-preventable diseases, including by assessing factors contributing to underutilization of vaccines and variations of such factors, and identifying communities at high risk of outbreaks associated with vaccine-preventable diseases.’’.
Page 1108. For an additional amount for expenses necessary to prepare for or respond to an influenza pandemic, $287,000,000; of which $252,000,000 shall be available until expended, for activities including the development and purchase of vaccine, antivirals, necessary medical supplies, diagnostics, and other surveillance tools: Provided, That notwithstanding section 496(b) of the PHS Act, funds may be used for the construction or renovation of privately owned facilities for the production of pandemic influenza vaccines and other biologics, if the Secretary 6 finds such construction or renovation necessary to secure sufficient supplies of such vaccines or biologics.
Page 1397. ASSISTANCE.—Of the funds appropriated by this Act under the heading ‘‘Economic Support Fund’’, not less than $15,000,000 shall be made available for programs that promote and defend freedom of expression and the independence of the media abroad.